Literature DB >> 16500927

Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.

Anja C Huizink1, Robert F Ferdinand, Jan van der Ende, Frank C Verhulst.   

Abstract

OBJECTIVE: To investigate whether using ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is preceded by symptoms of behavioural and emotional problems in childhood and early adolescence.
DESIGN: Prospective, longitudinal, population based study
SETTING: The Dutch province of Zuid-Holland. PARTICIPANTS: A sample of 1580 individuals, followed up across a 14 year period, from childhood into adulthood. MAIN OUTCOME MEASURES: The first assessment took place in 1983 before MDMA appeared as a recreational drug in the Netherlands and included the child behaviour checklist to obtain standardised parents' reports of their children's behavioural and emotional problems. Use of the drug was assessed with the composite international diagnostic interview 14 years later.
RESULTS: Eight syndrome scales of childhood behaviour were examined. Scores in the deviant range for the scales designated as anxious or depressed in childhood were significantly related to use of MDMA in adolescents and adults, resulting in an increased risk (hazard ratio 2.22, 95% confidence interval 1.20 to 4.11, P = 0.01).
CONCLUSIONS: Individuals with childhood symptoms of anxiety and depression may have an increased tendency to use MDMA in adolescence or young adulthood. Its effects are supposed to include enhanced feelings of bonding with other people, euphoria, or relaxation. Especially individuals with symptoms of anxiety or depression may be susceptible to these positive effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500927      PMCID: PMC1432198          DOI: 10.1136/bmj.38743.539398.3A

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  26 in total

1.  Associations between different diagnostic approaches for child and adolescent psychopathology.

Authors:  M C Kasius; R F Ferdinand; H van den Berg; F C Verhulst
Journal:  J Child Psychol Psychiatry       Date:  1997-09       Impact factor: 8.982

2.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Authors:  A C Parrott; T Buchanan; A B Scholey; T Heffernan; J Ling; J Rodgers
Journal:  Hum Psychopharmacol       Date:  2002-08       Impact factor: 1.672

3.  Mental health in Dutch children: (I). A cross-cultural comparison.

Authors:  F C Verhulst; G W Akkerhuis; M Althaus
Journal:  Acta Psychiatr Scand Suppl       Date:  1985

4.  Mental disorders in ecstasy users: a prospective-longitudinal investigation.

Authors:  Roselind Lieb; Christian G Schuetz; Hildegard Pfister; Kirsten von Sydow; Hans Wittchen
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

5.  Chronic MDMA (ecstasy) use, cognition and mood.

Authors:  K McCardle; S Luebbers; J D Carter; R J Croft; C Stough
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

Review 6.  The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors:  A Richard Green; Annis O Mechan; J Martin Elliott; Esther O'Shea; M Isabel Colado
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

7.  Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.

Authors:  Maartje M L de Win; Liesbeth Reneman; Johannes B Reitsma; Gerard J den Heeten; Jan Booij; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

8.  Mental health in Dutch children: (II). The prevalence of psychiatric disorder and relationship between measures.

Authors:  F C Verhulst; G F Berden; J A Sanders-Woudstra
Journal:  Acta Psychiatr Scand Suppl       Date:  1985

9.  Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.

Authors:  Suzanne L Verheyden; Rachel Maidment; H Valerie Curran
Journal:  J Psychopharmacol       Date:  2003-12       Impact factor: 4.153

10.  Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

Authors:  G Ricaurte; G Bryan; L Strauss; L Seiden; C Schuster
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

View more
  15 in total

1.  Ecstasy use and suicidal behavior among adolescents: findings from a national survey.

Authors:  Jueun Kim; Bin Fan; Xinhua Liu; Nancy Kerner; Ping Wu
Journal:  Suicide Life Threat Behav       Date:  2011-06-01

2.  Individual and peer factors associated with ketamine use among adolescents in Taiwan.

Authors:  Kun-Hua Lee; Yi-Chun Yeh; Pin-Chen Yang; Huang-Chi Lin; Peng-Wei Wang; Tai-Ling Liu; Cheng-Fang Yen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

3.  Ecstasy and the antecedents of illicit drug use.

Authors:  Kari Poikolainen
Journal:  BMJ       Date:  2006-04-08

4.  MDMA (Ecstasy) use and psychiatric problems.

Authors:  Casey R Guillot; Mitchell E Berman
Journal:  Psychopharmacology (Berl)       Date:  2006-10-24       Impact factor: 4.530

5.  Adolescent problem behaviours predicting DSM-IV diagnoses of multiple substance use disorder. Findings of a prospective birth cohort study.

Authors:  Mohammad Reza Hayatbakhsh; Jake Moses Najman; Konrad Jamrozik; Abdullah Al Mamun; William Bor; Rosa Alati
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

6.  The role of MDMA (Ecstasy) in coping with negative life situations among urban young adults.

Authors:  Lwendo S Moonzwe; Jean J Schensul; Kristin M Kostick
Journal:  J Psychoactive Drugs       Date:  2011 Jul-Sep

7.  Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins.

Authors:  Tellervo Korhonen; Anja C Huizink; Danielle M Dick; Lea Pulkkinen; Richard J Rose; Jaakko Kaprio
Journal:  Drug Alcohol Depend       Date:  2008-05-02       Impact factor: 4.492

8.  Early-onset depressive disorders predict the use of addictive substances in adolescence: a prospective study of adolescent Finnish twins.

Authors:  Elina Sihvola; Richard J Rose; Danielle M Dick; Lea Pulkkinen; Mauri Marttunen; Jaakko Kaprio
Journal:  Addiction       Date:  2008-10-08       Impact factor: 6.526

9.  What predicts illicit drug use versus police-registered drug offending? Findings from the Finnish "From a Boy to a Man" birth cohort study.

Authors:  Solja Niemelä; Andre Sourander; Henrik Elonheimo; Kari Poikolainen; Ping Wu; Hans Helenius; Jorma Piha; Kirsti Kumpulainen; Irma Moilanen; Tuula Tamminen; Fredrik Almqvist
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-04-26       Impact factor: 4.328

10.  Decision making as a predictor of first ecstasy use: a prospective study.

Authors:  Thelma Schilt; Anneke E Goudriaan; Maarten W Koeter; Wim van den Brink; Ben Schmand
Journal:  Psychopharmacology (Berl)       Date:  2008-11-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.